Barrett & Company’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$185K Buy
684
+203
+42% +$60.5K 0.06% 157
2025
Q4
$159K Sell
481
-664
-58% -$225K 0.05% 173
2025
Q3
$395K Sell
1,145
-36
-3% -$10.9K 0.14% 95
2025
Q2
$368K Buy
1,181
+262
+29% +$100K 0.14% 100
2025
Q1
$481K Hold
919
0.21% 82
2024
Q4
$465K Hold
919
0.2% 80
2024
Q3
$537K Hold
919
0.23% 76
2024
Q2
$468K Sell
919
-100
-10% -$49K 0.21% 78
2024
Q1
$504K Sell
1,019
-45
-4% -$22.9K 0.24% 75
2023
Q4
$560K Buy
1,064
+165
+18% +$88K 0.3% 64
2023
Q3
$453K Hold
899
0.27% 74
2023
Q2
$432K Buy
899
+245
+37% +$120K 0.25% 78
2023
Q1
$309K Sell
654
-161
-20% -$77.7K 0.2% 93
2022
Q4
$432K Hold
815
0.29% 72
2022
Q3
$432K Buy
+815
New +$429K 0.29% 72

Other funds holding UNH

Barrett & Company's UNH Position: Q1 2026 in Review

Barrett & Company increased its UnitedHealth (UNH) stake by 42% in Q1 2026, buying an estimated $60.5K and bringing the position to 684 shares worth $185K. The position accounts for 0.06% of the portfolio, ranked #157.

Barrett & Company first reported a position in UNH in Q3 2022 and has held it in 15 quarters since. The position peaked at $560K in Q4 2023. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Barrett & Company held 684 shares of UnitedHealth worth $185K as of Q1 2026.
  • Barrett & Company bought 203 UnitedHealth shares in Q1 2026, an estimated $60.5K.
  • UnitedHealth made up 0.06% of Barrett & Company's portfolio in Q1 2026, its #157 holding.
  • Barrett & Company first reported a position in UnitedHealth in Q3 2022 and has held it in 15 quarters since.
  • Barrett & Company's UnitedHealth position peaked at $560K in Q4 2023.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.